ConductScience.org, home

Paper36958539

Integration of miRNA's theranostic potential with nanotechnology: Promises and challenges for Parkinson's disease therapeutics.

Tryphena KP and 6 others. Mech Ageing Dev, 2023. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Integration of miRNA's theranostic potential with nanotechnology: Promises and challenges for Parkinson's disease therapeutics. Papers, record 36958539. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36958539

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Integration of miRNA's theranostic potential with nanotechnology: Promises and challenges for Parkinson's disease therapeutics.
PubMed
Journal
Mech Ageing Dev
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
3.6
iCite
Revised in PubMed
2023-04-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tryphena KPKamatham Pushpa
2Singh GGurpreet
3Jain NNaitik
4Famta PParas
5Srivastava SSaurabh
6Singh SBShashi Bala
7Khatri DKDharmendra Kumar

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicroRNAsMajor topic
Parkinson DiseaseMajor topic
Humans
Precision Medicine
Brain
Blood-Brain Barrier

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42653169Theranostic Innovative Strategies for Brain Diseases: New Insights on Neurovascular Unit-Associated Pathological Changes in Neurodegenerative Disorders and Aging.Int J Mol Sci2026https://conductscience.org/library/papers/42653169PubMed
42204625MicroRNA-7: a versatile player and core target in brain disorders.J Transl Med2026https://conductscience.org/library/papers/42204625PubMed
41296066Non-coding RNAs in Parkinson's Disease: Pathogenesis, Exosomes, and Therapeutic Horizons.Cell Mol Neurobiol2025https://conductscience.org/library/papers/41296066PubMed
41204267Biomimetic nanodelivery system with simultaneous blood-brain barrier-crossing and neuroprotective abilities for anti-parkinsonian therapy.Chin Med2025https://conductscience.org/library/papers/41204267PubMed
40587016Genetic variants in oncogenic miRNA and 3' untranslated region of tumor suppressor genes: emerging insight into cancer genetics.Med Oncol2025https://conductscience.org/library/papers/40587016PubMed
40227305Quercetin loaded-magnetic zeolite nano-composite material and evaluate its anti-cancer effect.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40227305PubMed
40100493New Insights on the Potential Role of Pyroptosis in Parkinson's Neuropathology and Therapeutic Targeting of NLRP3 Inflammasome with Recent Advances in Nanoparticle-Based miRNA Therapeutics.Mol Neurobiol2025https://conductscience.org/library/papers/40100493PubMed
40085354Neurotoxic Effects of Atrazine on Dopaminergic System via miRNAs and Energy-Sensing Pathways.Mol Neurobiol2025https://conductscience.org/library/papers/40085354PubMed
40056236LncRNAs Orchestrating Neuroinflammation: A Comprehensive Review.Cell Mol Neurobiol2025https://conductscience.org/library/papers/40056236PubMed
39695016MicroRNA signatures in neuroplasticity, neuroinflammation and neurotransmission in association with depression.J Physiol Biochem2025https://conductscience.org/library/papers/39695016PubMed
39604129Effect of Transferrin-Modified Fe3O4 Nanoparticle Targeted Delivery miR-15a-5p Combined With Photothermal Therapy on Lung Cancer.Thorac Cancer2025https://conductscience.org/library/papers/39604129PubMed
39514132Mitophagy Unveiled: Exploring the Nexus of Mitochondrial Health and Neuroendocrinopathy.J Mol Neurosci2024https://conductscience.org/library/papers/39514132PubMed
39223566Diagnostic value of miR-34a in Mycoplasma pneumoniae pneumonia in children and its correlation with rehabilitation effect.J Cardiothorac Surg2024https://conductscience.org/library/papers/39223566PubMed
39162871MicroRNAs Modulating Neuroinflammation in Parkinson's disease.Inflammation2025https://conductscience.org/library/papers/39162871PubMed
38800624Mitochondria-Associated MicroRNAs and Parkinson's Disease.Neurosci Insights2024https://conductscience.org/library/papers/38800624PubMed
38346718Calcitriol restrains microglial M1 polarization and alleviates dopaminergic degeneration in hemiparkinsonian mice by boosting regulatory T-cell expansion.Brain Behav2024https://conductscience.org/library/papers/38346718PubMed
38010378Deeper insight into ferroptosis: association with Alzheimer's, Parkinson's disease, and brain tumors and their possible treatment by nanomaterials induced ferroptosis.Redox Rep2023https://conductscience.org/library/papers/38010378PubMed
37814337The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease.J Transl Med2023https://conductscience.org/library/papers/37814337PubMed
37541971PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson's disease in rats.Inflammopharmacology2024https://conductscience.org/library/papers/37541971PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36958539

GET https://conductscience.org/api/papers/v1/36958539/authors